INFLUENCE OF THE EXPRESSION OF E7 PROTEIN ON GROWTH FACTORS AND MARKER OF SQUAMOUS CELL CARCINOMA SСC IN THE TISSUE OF CERVICAL CANCER

DOI: https://doi.org/None

E.M. Frantsiyants, T.I. Moiseenko, Yu.A. Pogorelova, V.P. Nikitina, D.A. Spiridonova, O.G. Selezneva, K.P. Boyko Rostov Cancer Research Institute, 14th line, 63, Rostov-on-Don, 344037, Russian Federation

Introduction. Study of growth factors content in tumors of different localizations and assessment of their probable correlation with the main clinical and morphological characteristics are relevant nowadays. Products of expression of the viral genome – E7 and E6 proteins – are considered to participate in malignant transformation of cervical epithelial tissue. The aim of the study. Study of the effect of E7 protein on the level of growth factors and their receptors in tissue of endophytic and exophytic cervical cancer. Methods. In tissues of tumor, its perifocal zone and visually unchanged tissues obtained during surgical treatment of 46 patients with histologically confirmed squamous cell carcinoma of the cervix (endophytic – n=22, exophytic – n=24) T1b-2aN0M0 there were studied levels of VEGF, VEGFR, EGF, EGFR, SСC and E7 protein by ELISA. Results. In visually unchanged tissue and in tumor tissue VEGF level increased by 1,8 and 3,7 times respectively, and VEGF-R level increased by 1,8 and 2,1 times respectively in exophytic type of growth in E7-positive samples. The indices in endophytic type of growth increased by 3,1 and 8,8 times respectively. E7 presence in cervical cancer tissues increased the content of SCC marker by 2,5 times on average. Conclusion. After the comparison of E7 protein effect on activation of growth factors in tissue of carcinoma of the uterine cervix in two growth factors, it is possible to suppose that E7 contributes to increasing activation of VEGF-А – angiogenesis signaling pathway – in exophytic tumor tissue, while, on the contrary, E7 limits its activity in endophytic tumor tissue. The reasons of different effect of E7 protein on angiogenic activity of exophytic and endophytic tumors of the uterine cervix remain to be seen, but the results of the study confirm more aggressive course of endophytic growth pattern of carcinoma of the uterine cervix.
Keywords: 
endophytic and exophytic carcinoma of the uterine cervix, growth factors, E7 protein

Список литературы: 
  1. Jain R.K., Duda D.G., Clark J.W., Loeffler J.S. Lessonsfromphase III clinical trialsonanti-EGF therapyfor cancer. Natl. Clin. Pract. Oncol. 2006; 3 (1); 24–40.
  2. Kiselev V.I. Virusy papillomy cheloveka v razvitii raka sheyki matki. M., 2004; 184.[Kiselev V.I. Virusy papillomy cheloveka v razvitii raka shejki matki. M., 2004; 184 (in Russian)]
  3. Mal`ceva L.I. Ocenka riska zlokachestvennoy transformacii e`piteliya sheyki matki pri VPCh-associirovannom cervicite. Voprosy ginekologii, akusherstva i perinatologii. 2012; 11 (4); 53–7.[Mal’ceva L.I. Ocenka riska zlokachestvennoj transformacii jepitelija shejki matki pri VPCh-associirovannom cervicite. Voprosy ginekologii, akusherstva i perinatologii. 2012; 11 (4); 53–7 (in Russian)]
  4. Munger K., Howley P.M. Human papilloma virus immortalization and transformation functions. Virus Res. 2002; 89; 213–28.
  5. Shherbakov A.M., Gershteyn E.S., Anurova O.A., Kushlinskiy N.E. Faktor rosta e`ndoteliya sosudov, ego receptory i antiapoptoticheskie belki BCL-2 i akt pri rake molochnoy zhelezy. Mammologiya. 2006; 3: 63–8.[Shherbakov A.M., Gershtejn E.S., Anurova O.A., Kushlinskij N.E. Faktor rosta jendotelija sosudov, ego receptory i antiapoptoticheskie belki BCL-2 i akt pri rake molochnoj zhelezy . Mammologija. 2006; 3: 63–8 (in Russian)]
  6. Kushlinskiy N.E., Trapeznikova M.F., Gershteyn E.S., Glybin P.V., Kazanceva I.A., Kylychbekov M.B. Faktor rosta e`ndoteliya sosudov i ego receptor 2-go tipa v opuholyah i syvorotke krovi bol`nyh rakom pochki. Byulleten` e`ksperimental`noy biologii i mediciny. 2008;145 (6); 691–4.[Kushlinskij N.E., Trapeznikova M.F., Gershtejn E.S., Glybin P.V., Kazanceva I.A., Kylychbekov M.B. Faktor rosta jendotelija sosudov i ego receptor 2-go tipa v opuholjah i syvorotke krovi bol’nyh rakom pochki. Bjulleten’ jeksperimental’noj biologii i mediciny. 2008; 145 (6); 691–4 (in Russian)]
  7. Fridman M.V., Demidchik Yu.E. Angiogenez i rak – mediko-biologicheskoe znachenie, metody ocenki, perspektivy dal`neyshego izucheniya. Onkologicheskiy zhurnal. 2009; 2 (10); 82–90.[Fridman M.V., Demidchik Ju.E. Angiogenez i rak – mediko-biologicheskoe znachenie, metody ocenki, perspektivy dal’nejshego izuchenija. Onkologicheskij zhurnal. 2009; 2 (10); 82–90 (in Russian)]
  8. McDonald D.M., Foss A.J.E. Endothelial cells of tumor vessels: abnormal but not absent. Cancer Metastasis Rev. 2000; 19: 109–20.
  9. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science.1983; 219: 983–5.
  10. Ferrara N., Gerber H.P., Le Couter J. The biology of VEGF and its receptors. Nat. Med. 2003; 9: 669–76.
  11. Bridges A.J. The rationale and strategy used to develop a series of highly potent, irreversible, inhibitors of the epidermal growth factor receptor family of tyrosine kinase. Curr. Med. Chem. 1999; 6: 825–43.